45-101 : Drug Use-Results Survey of ONOACT

45-101 : Drug Use-Results Survey of ONOACT(the following tachyarrhythmias associated with sepsis: atrial fibrillation, atrial flutter, sinus tachycardia)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT2041240118

Enrollment

200

Registered

2024-11-05

Start date

2021-01-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tachyarrhythmias associated with sepsis: atrial fibrillation, atrial flutter, sinus tachycardia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with the following tachyarrhythmias associated with sepsis: atrial fibrillation, atrial flutter, sinus tachycardia, who have recieved ONOACT for the first time

Exclusion criteria

Exclusion criteria: Patients who have received ONOACT previously

Design outcomes

Primary

Measure	Time frame
Safety items : Occurrence of adverse drug reactions and infections set as safety specifications, factors considered to influence the safety, background factors that may influence life prognosis	—

Contacts

Public ContactTakafumi Nakao

Ono Pharmaceutical Co.,LTD

pms_contact_ml@ono-pharma.com+81-6-6222-5501

Outcome results